Pharmacology of a nicotinamido-methylaminopyrazolone (Ra 101).
D000632:Aminopyrine / Q000494:pharmacology; D000661:Amphetamine / Q000037:antagonists & inhibitors*; D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D000927:Anticonvulsants / Q000494:pharmacology*; D002351:Carrageenan / Q000037:antagonists & inhibitors; D003436:Croton Oil / Q000037:antagonists & inhibitors; D003864:Depression, Chemical; D003911:Dextrans / Q000037:antagonists & inhibitors; D004357:Drug Synergism; D004487:Edema / Q000517:prevention & control; D005260:Female; D005334:Fever / Q000517:prevention & control; D005984:Glutethimide / Q000494:pharmacology; D006099:Granuloma / Q000517:prevention & control; D006591:Hexobarbital / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006993:Hypnotics and Sedatives / Q000494:pharmacology*; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D010653:Phenylbutazone / Q000494:pharmacology; D011135:Polysaccharides, Bacterial / Q000037:antagonists & inhibitors; D011720:Pyrazoles / Q000494:pharmacology* / Q000652:urine; D011817:Rabbits; D051381:Rats; D012640:Seizures / Q000517:prevention & control
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D000927:Anticonvulsants; D003911:Dextrans; D006634:Histamine H1 Antagonists; D006993:Hypnotics and Sedatives; D011135:Polysaccharides, Bacterial; D011720:Pyrazoles; D000632:Aminopyrine; D003436:Croton Oil; D002351:Carrageenan; D006591:Hexobarbital; D005984:Glutethimide; D000661:Amphetamine; D010653:Phenylbutazone; D010433:Pentylenetetrazole